Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
Journal of Alzheimer's Disease(3)
Age(1)
Biochimica et Biophysica Acta - Molecular Basis of Disease(1)
Current Neuropharmacology(1)
Current Neurovascular Research(1)
Área temáticas
Fisiología humana(8)
Enfermedades(6)
Ganadería(1)
Ingeniería química(1)
Medicina y salud(1)
Origen
scopus(9)
Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8
ArticleAbstract: Resveratrol is a polyphenol that is mainly found in grapes and red wine and has been reported to bePalabras claves:Alzheimer's disease, AMPK, Memory impairment, Resveratrol, Senescence, Sirtuin 1, Tau, β-AmyloidAutores:Antoni Camins, Bayod S., Canudas A.M., Casadesús G., Del Valle J., Pallás M., Pelegrí Gabalda C., Porquet D., Sanfeliu C., Vicente A., Vilaplana J.Fuentes:scopusExperimental models for aging and their potential for novel drug discovery
ReviewAbstract: Background: An interesting area of scientific research is the development of potential antiaging druPalabras claves:aging, Heterogeneous mice model, IGF-1, mTOR, Resveratrol, SAMP8, SirtuinsAutores:Antoni Camins, Auladell C., Busquets O., Casadesús G., Ettcheto M., Folch J., Miguel Marin, Olloquequi J., Pallás M., Sanchez-Lopez E., Zárate C.B.Fuentes:scopusEarly alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease
ArticleAbstract: The present study had focused on the behavioral phenotype and gene expression profile of molecules rPalabras claves:Alzheimer's disease, APPswe/PS1dE9, hippocampus, insulin receptor, Mitochondria, TauAutores:Allgaier M., Antoni Camins, Auladell C., Barroso E., Casadesús G., Folch J., Pallás M., Pedros I., Petrov D., Sureda F.X., Vázquez-Carrera M., Zárate C.B.Fuentes:scopusNeuroprotective effects of the amylin analog, pramlintide, on Alzheimer's disease are associated with oxidative stress regulation mechanisms
ArticleAbstract: Administration of the recombinant analog of the pancreatic amyloid amylin, Pramlintide, has shown thPalabras claves:Alzheimer's disease, amylin, metabolism, neuroprotection, Oxidative Stress, pramlintideAutores:Antoni Camins, Blair J., Casadesús G., Corrigan R., Grizzanti J., Lee H.g., Mey M., Pallás M., Patrick S.Fuentes:scopusMemantine for the treatment of dementia: A review on its current and future applications
ReviewAbstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence in the brainPalabras claves:Alzheimer's disease, Amyloid-protein, Extrasynaptic N-Methyl-D-aspartate receptor, Memantine, Tau proteinAutores:Antoni Camins, Auladell C., Busquets O., Casadesús G., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Olloquequi J., Pelegrí Gabalda C., Sanchez-Lopez E., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusPharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease
ReviewAbstract: To deeply understand late onset Alzheimer's disease (LOAD), it may be necessary to change the concepPalabras claves:BDNF, dendritic spines, late onset Alzheimer's disease, neuroinflammation, obesity, Type 2 Diabetes mellitusAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Casadesús G., Castro-Torres R.D., Espinosa-Jimenez T., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Sureda F.X., Verdaguer E.Fuentes:scopusLithium treatment decreases activities of tau kinases in a murine model of senescence
ArticleAbstract: Lithium modulates glycogen synthase kinase 3β (GSK-3β), a kinase involved in Alzheimer disease-relatPalabras claves:aging, BRAIN, Lithium, Neurodegeneration, Senescence-accelerated mouseAutores:Antoni Camins, Caballero B., Casadesús G., Ferrer I., Folch J., Gutiérrez-Cuesta J., Pallás M., Smith M.A., Tajes M.Fuentes:scopusResveratrol and neurodegenerative diseases: Activation of SIRT1 as the potential pathway towards neuroprotection
ReviewAbstract: One of the current problems in medicine research is the development of safe drugs for the treatmentPalabras claves:Autores:Antoni Camins, Casadesús G., Coto-Montes A., Pallás M., Pelegrí Gabalda C., Smith M.A., Vilaplana J.Fuentes:scopusThe therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease
ReviewAbstract: Aging leads to a number of physiological alterations, specifically changes in circulating hormone lePalabras claves:Alzheimer disease, amylin, DIABÉTES, Insulin, leptin, obesityAutores:Antoni Camins, Casadesús G., Grizzanti J., Lee H.g., Pallás M.Fuentes:scopus